About VetBiotek
VetBiotek is a company based in Largo (United States) founded in 2014 was acquired by Nextmune in December 2023. VetBiotek offers products and services including Dermatology Products and Joint Support Products. VetBiotek operates in a competitive market with competitors including Zoetis, Ceva, PetMedix, QBiotics and Bio-Sourcing, among others.
- Headquarter Largo, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Vetbiotek, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of VetBiotek
VetBiotek offers a comprehensive portfolio of products and services, including Dermatology Products and Joint Support Products.
Products for treating animal skin conditions effectively.
Supplements to enhance animal joint health and mobility.
Funding Insights of VetBiotek
Detailed funding history for VetBiotek
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in VetBiotek
VetBiotek has secured backing from 1 investor. Prominent investors backing the company include Nextmune.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Global company offering pet health products in allergy, dermatology, and nutrition services.
|
Locked | Locked | Locked |
Investor details for VetBiotek
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by VetBiotek
Investment portfolio details for VetBiotek
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - VetBiotek
Detailed financials for VetBiotek
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vetbiotek Comparisons
Peer comparison for VetBiotek
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of VetBiotek
VetBiotek operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Zoetis, Ceva, PetMedix, QBiotics and Bio-Sourcing, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Animal medicines, vaccines, and diagnostics are manufactured and supplied.
|
|
| Locked | Locked | Locked |
Animal health therapeutics are developed and supplied globally by Ceva.
|
|
| Locked | Locked | Locked |
Developer of monoclonal antibody therapeutics for pets
|
|
| Locked | Locked | Locked |
Small molecules from plant extracts are developed for medical applications.
|
|
| Locked | Locked | Locked |
Biopharmaceuticals for animals are manufactured and supplied through partnerships.
|
|
| Locked | Locked | Locked |
Manufacturer of animal vaccines and healthcare products
|
Detailed competitors of VetBiotek
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vetbiotek
Complete news archive for VetBiotek
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about VetBiotek
VetBiotek was founded in 2014.
VetBiotek is headquartered in Largo, United States. It is registered at Largo, Florida, United States.
Thomas Bell is the current CEO of VetBiotek.
VetBiotek was founded in 2014 in Largo, United States, operating in the veterinary medicine sector. Products including MicroSilver BG, Ceramide III, AyuFlex, BiovaPlex, UC-II, and VitaBerry are supplied to address dermatology cases, liver disease, and joint support. These offerings assist veterinarians in handling common animal health issues through targeted formulations.
VetBiotek offers Dermatology Products and Joint Support Products.
VetBiotek has 1 investor. Key investors include Nextmune.